Items Tagged ‘Prostvac’

June 1st, 2015

Prostvac® Vaccine Promising in Treatment of Metastatic Castration-Resistant Prostate Cancer


The prostate cancer vaccine Prostvac® (rilimogene galvacirepvec/rilimogene glafolivec) may be active in combination with Yervoy® (ipilimumab) in the treatment of metastatic prostate cancer that does not respond to hormone therapy. These findings were presented at the 2015 Genitourinary Cancers Symposium on February 26–28 in Orlando, Florida. Prostate cancer is a hormonally sensitive disease that can […]

View full entry

Tags: castration resistant, crpc, glafolivec, Metastatic Stage IV (D) Prostate Cancer, News, Prostate Cancer, Prostvac, Yervoy